Most of the AML cases without recurrent genetic abnormalities (including AML with MDS related changes, not otherwise specified (NOS) and therapyrelated cases) showed a similar phenotype with changes in CD38 (usually CD38lo) and characteristics of early progenitors. This evidence concerns the gene CD38 and myelodysplastic syndrome.